These final results, together with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 help the strategy of focusing on ACKR3 as a singular strategy to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-relevant disorders. Disclaimer: The above https://conolidineisnotanopioid22097.blog2news.com/34250248/the-single-best-strategy-to-use-for-conolidine